Avoro Capital Advisors LLC Amicus Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

$6.86 Billion
Q4 2024

A detailed history of Avoro Capital Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 23,175,000 shares of FOLD stock, worth $211 Million. This represents 3.18% of its overall portfolio holdings.

Number of Shares

23,175,000

Previous 23,175,000 -0.0%

Holding current value

$211 Million

Previous $248 Million 11.8%

% of portfolio

3.18%

Previous 3.72%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $40.3 Million - $51.1 Million	-4,225,000 Reduced 15.42%	23,175,000 $248 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $1.07 Million - $1.33 Million	100,000 Added 0.37%	27,400,000 $344 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $5.46 Million - $6.77 Million	500,000 Added 1.87%	27,300,000 $303 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $39.2 Million - $70.1 Million	6,300,000 Added 30.73%	26,800,000 $288 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $15.8 Million - $25 Million	2,000,000 Added 10.81%	20,500,000 $194 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $8.06 Million - $10.2 Million	820,727 Added 4.64%	18,500,000 $214 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $45.7 Million - $61.9 Million	5,229,273 Added 42.0%	17,679,273 $169 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $1.74 Million - $2.14 Million	200,000 Added 1.63%	12,450,000 $120 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $29.9 Million - $77.5 Million	3,250,000 Added 36.11%	12,250,000 $121 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $24.9 Million - $46 Million	-1,850,000 Reduced 17.05%	9,000,000 $208 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $1.93 Million - $2.38 Million	-150,000 Reduced 1.36%	10,850,000 $153 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $443,000 - $784,500	50,000 Added 0.46%	11,000,000 $166 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $1.66 Million - $2.79 Million	-250,000 Reduced 2.23%	10,950,000 $101 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $748,000 - $1.08 Million	100,000 Added 0.9%	11,200,000 $109 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $8.82 Million - $14.6 Million	1,100,000 Added 11.0%	11,100,000 $89 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $5.48 Million - $7.2 Million	500,000 Added 5.26%	10,000,000 $125 Million
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $6.27 Million - $8.7 Million	-625,000 Reduced 6.17%	9,500,000 $129 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $6.64 Million - $10.6 Million	791,868 Added 8.48%	10,125,000 $97 Million
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $417,808 - $595,737	-36,018 Reduced 0.38%	9,333,132 $113 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $1.79 Million - $2.33 Million	-136,297 Reduced 1.43%	9,369,150 $146 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $30.9 Million - $38.4 Million	2,242,325 Added 30.87%	9,505,447 $143 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $10.3 Million - $13.4 Million	826,000 Added 12.83%	7,263,122 $105 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $75.6 Million - $102 Million	6,437,122	6,437,122 $97.1 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

311M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.56B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Amicus Therapeutics, Inc. Transaction History